OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year
Wilson Hu, Michele Thornton, Robert A. Livingston
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 2, pp. 327-332
Open Access | Times Cited: 9
Wilson Hu, Michele Thornton, Robert A. Livingston
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 2, pp. 327-332
Open Access | Times Cited: 9
Showing 9 citing articles:
Ruxolitinib Cream 1.5%: A Review in Non-Segmental Vitiligo
Connie Kang
Drugs (2024) Vol. 84, Iss. 5, pp. 579-586
Open Access | Times Cited: 4
Connie Kang
Drugs (2024) Vol. 84, Iss. 5, pp. 579-586
Open Access | Times Cited: 4
Recent clinical and mechanistic insights into vitiligo offer new treatment options for cell-specific autoimmunity
Khaled Ezzedine, Rim Tannous, T. Pearson, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 2
Closed Access
Khaled Ezzedine, Rim Tannous, T. Pearson, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 2
Closed Access
Topical Medications for Chronic Itch in Older Patients: Navigating a Pressing Need
Brooke R. Bartley, Christina M. Pierce, Chad Hivnor, et al.
Drugs & Aging (2025)
Closed Access
Brooke R. Bartley, Christina M. Pierce, Chad Hivnor, et al.
Drugs & Aging (2025)
Closed Access
Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database
J. Z. Liu, Karishma Desai, Chia‐Chen Teng, et al.
ClinicoEconomics and Outcomes Research (2025) Vol. Volume 17, pp. 69-77
Open Access
J. Z. Liu, Karishma Desai, Chia‐Chen Teng, et al.
ClinicoEconomics and Outcomes Research (2025) Vol. Volume 17, pp. 69-77
Open Access
The future of topical JAK inhibitors in the treatment of atopic dermatitis
Joanna Mazgaj, Magdalena Kotewicz, Andrzej Jaworek, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Joanna Mazgaj, Magdalena Kotewicz, Andrzej Jaworek, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Canadian Consensus Guidelines for the Management of Atopic Dermatitis with Topical Therapies
Melinda Gooderham, Chih-ho Hong, Charles Lynde, et al.
Dermatology and Therapy (2025)
Open Access
Melinda Gooderham, Chih-ho Hong, Charles Lynde, et al.
Dermatology and Therapy (2025)
Open Access
Biologics Versus JAK Inhibitors. Part I: Cancer Risk. A Narrative Review
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 6, pp. 1389-1442
Open Access | Times Cited: 3
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 6, pp. 1389-1442
Open Access | Times Cited: 3
JAK Inhibitors in Immune Regulation and Treatment of Vitiligo
Kewei Liu, Linyi Zhou, Meihui Shi, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 80, pp. 87-96
Closed Access | Times Cited: 1
Kewei Liu, Linyi Zhou, Meihui Shi, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 80, pp. 87-96
Closed Access | Times Cited: 1
Review of modern methods of treating vitiligo
E. V. Bazhenova, M. S. Kruglova
Medical alphabet (2024), Iss. 9, pp. 12-16
Closed Access
E. V. Bazhenova, M. S. Kruglova
Medical alphabet (2024), Iss. 9, pp. 12-16
Closed Access
